OceanIQ Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.37M Buy
8,646
+58
+0.7% +$14.9K 1.25% 15
2026
Q2
$2.15M Hold
8,588
– – 1.3% 13

Other funds holding ABBV

OceanIQ Capital's ABBV Position: Q3 2026 in Review

OceanIQ Capital increased its AbbVie (ABBV) stake by 0.68% in Q3 2026, buying an estimated $14.9K and bringing the position to 8,646 shares worth $2.37M. The position accounts for 1.25% of the portfolio, ranked #15.

OceanIQ Capital first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • OceanIQ Capital held 8,646 shares of AbbVie worth $2.37M as of Q3 2026.
  • OceanIQ Capital bought 58 AbbVie shares in Q3 2026, an estimated $14.9K.
  • AbbVie made up 1.25% of OceanIQ Capital's portfolio in Q3 2026, its #15 holding.
  • OceanIQ Capital first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on OceanIQ Capital's 13F filing for Q3 2026, filed 19 Oct 2026.